New factor required for hepatitis C infection
Nature Medicine
October 11, 2010
An article in this week’s Nature Medicine reports that the enzyme DGAT1 — important for the metabolism of lipids — is necessary for hepatitis C infection and could be a new target for antiviral therapy.
Over 160 million people are infected with hepatitis C virus (HCV), and infection can lead to severe liver disease in many cases. Hepatitis C infection is closely linked to fat metabolism in liver cells.
Melanie Ott and her team have identified the lipid-synthesizing enzyme DGAT1 as a key host factor for HCV infection. DGAT1 interacts with the virus and is required for its trafficking to lipid droplets in human cells. Inhibition of DGAT1 activity severely impairs viral production, implicating DGAT1 as a potential therapeutic target.
doi: 10.1038/nm.2238
Research highlights
-
Dec 2
Palaeontology: New predatory diving dinosaur species identifiedCommunications Biology
-
Dec 2
Planetary science: Mars megatsunami may have been caused by Chicxulub-like asteroid impactScientific Reports
-
Dec 2
Archaeology: Owl-shaped plaques may have been on Copper Age children’s wish listScientific Reports
-
Dec 1
Fossils: Cretaceous bird may lead to evolutionary rethinkNature
-
Nov 30
Health: Fine particulate air pollution may be associated with increased stillbirthsNature Communications
-
Nov 30
Health: Risk factors associated with long COVID in adolescentsNature Communications
